MD Medical Group Investments Plc (MDMG.L)
ValueMarkers Composite Index
DCF data not available
MD Medical Group Investments Plc (MDMG.L) — VMCI valuation read
Headline read on MDMG.L: VMCI of 73/100 versus a Healthcare sector median of 50. The 23-point above-median position is what makes MD Medical Group Investments Plc a relative-value candidate in the mid-cap cohort, before any pillar-level review.
Form 4 filings on MDMG.L: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.
**Investor frame.** Three reads on MDMG.L: value (MDMG.L trades at 15.0x earnings, 17% below the Healthcare median of 18.0x), quality (ROIC of 19.0% sits 9.0pp above the Healthcare median (10.0%)), and risk (net debt to EBITDA of 0.1x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the Healthcare 12.0x baseline.
MDMG.L rose 3.0% over the trailing 7 days, with a -5.0% read on a 30-day basis.
MD Medical Group Investments Plc, an investment holding company, provides healthcare services for women and children in Russia. It offers a range of services in the areas of obstetrics and gynaecology, fertility and IVF treatment, and pediatrics, as well as diagnostics, urology, radiology, surgery, traumatology, rehabilitation, cardiology, oncology, endovascular, laboratory examinations, and other services. The company also retails pharmaceutics; and provides assistance services. As of March 28, 2022, it managed 47 healthcare facilities, including 8 hospitals and 39 out-patient clinics in 27 cities and 25 regions. The company was founded in 2006 and is based in Nicosia, Cyprus. MD Medical Group Investments Plc is a subsidiary of MD Medical Holding Limited.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.